group profile


Stated Mission

Foregen’s goal is to heal the physical detriment that that is inherent to circumcision. Research undeniably demonstrates the functional and sensory losses to the penis when circumcised, as well as the potential for psychological damage for those on whom such surgery was performed. Fortunately, regenerative medical techniques now offer a greater possibility than ever to regrow human tissue, especially dermal tissue, lost in prior trauma. However, those techniques have not yet been applied to those who have been circumcised and no longer wish to be.

Foregen was founded to promote and arrange a clinical trial that would use regenerative techniques to regrow the tissue removed at circumcision. After dismissing many unsatisfactory proposals from research institutions, we have decided to conduct our own research and clinical trials. With the help of dedicated scientists, we will apply known regenerative techniques to the foreskin in order to restore normal penile function and sensitivity.


Legal Name

Foregen USA, Inc.

Year Incorporated  2012

Year Granted Tax-Exempt Status  2012

EIN  98-1006983

Executive Director   Vincenzo Aiello

Board of Directors
Vincenzo Aiello
Carlo Alberto Cirioni
Tyler Drozd
Peter Benson



Latest Reporting Year   2016

Revenue  $ 93,425

Expenses  $ 58,320

Compensation Paid to Executive Director  declined to report

Assets  $ 100,112

Government Filings

IRS 990 Tax Returns

Guide-to-Giving Survey Results

Foregen did not respond to our survey request.

Notes and Analysis